Neuphoria Therapeutics had a revenue of 15.00M in the quarter ending Mar 31, 2025, with 2163.42%. This bring the company's revenue in the last twelve months to 15.66M, Decreased 2263.42%. In the fiscal year ending Jun 30, 2024, Neuphoria Therapeutics had annual revenue of 0.00 with -100.00% growth.